Healing Pathology: Keloid Scar

Article Sidebar

PDF
Published: Apr 6, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i4-09
Keywords:
.

Main Article Content

Jesús Ricardo Rivera Hernández
General Surgery Department, UMAE Hospital de Especialidades No. 71 CMN Torreón, IMSS

Abstract

Skin conditions known as keloid scars can afflict people of all ages and ethnicities. The description, features, and potential risk factors for this ailment are covered in the introduction.


I provide a thorough analysis of the etiology, administration, mitigation, and therapy of keloid scars. The distinctions between keloid scars and hypertrophic scars, the causes of keloid scar development, and the surgical and non-surgical therapies that are available are all discussed.


The discussion focuses on the main issues and factors in the management of keloid scars. The necessity of prevention and the need for a customized and interdisciplinary approach are explored, along with the current therapy techniques and their individual limitations.


The conclusion reviews the material covered in the earlier parts and highlights the value of prevention, selecting a therapy that is tailored to the patient's particular needs, and the necessity for more study into the pathophysiology of keloid scars.

Article Details

How to Cite
Jesús Ricardo Rivera Hernández. (2023). Healing Pathology: Keloid Scar. International Journal of Medical Science and Clinical Research Studies, 3(4), 632–634. https://doi.org/10.47191/ijmscrs/v3-i4-09
Issue
Vol. 3 No. 4 (2023): Volume 03 Issue 04 April 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Thornton, N. J., Garcia, B. A., Hoyer, P., & Wilkerson, M. G. (2021). Keloid scars: an updated review of combination therapies. Cureus, 13(1).

II. Elazhary, E. A., Al-Salam, A., El-Hafiz, A., Hala, S., & Maghraby, H. M. (2022). Updates on keloid scar pathogenesis, assessment and treatment modalities. Journal of Recent Advances in Medicine, 3(1), 75-86.

III. Elsaie, M. L. (2021). Update on management of keloid and hypertrophic scars: A systemic review. Journal of Cosmetic Dermatology, 20(9), 2729-2738.

IV. Nangole, F. W., & Agak, G. W. (2019). Keloid pathophysiology: fibroblast or inflammatory disorders?. JPRAS open, 22, 44-54.

V. Tsai, C. H., & Ogawa, R. (2019). Keloid research: current status and future directions. Scars, burns & healing, 5, 2059513119868659.

VI. Huang, C., Liu, L., You, Z., Du, Y., & Ogawa, R. (2019). Managing keloid scars: From radiation therapy to actual and potential drug deliveries. International wound journal, 16(3), 852-859.

VII. Betarbet, U., & Blalock, T. W. (2020). Keloids: a review of etiology, prevention, and treatment. The Journal of clinical and aesthetic dermatology, 13(2), 33.

VIII. Hawash, A. A., Ingrasci, G., Nouri, K., & Yosipovitch, G. (2021). Pruritus in keloid scars: mechanisms and treatments. Acta dermato-venereologica, 101(10), adv00582-adv00582.

IX. Abd El‐Dayem, D. H., Nada, H. A., Hanafy, N. S., & Elsaie, M. L. (2021). Laser‐assisted topical steroid application versus steroid injection for treating keloids: a split side study. Journal of Cosmetic Dermatology, 20(1), 138-142.